Genostics

Sydney, Australia Founded: 2010 • Age: 16 yrs
Offers personalized cancer testing, monitors treatment effectiveness, and tracks cancer status closely.

About Genostics

Genostics is a Healthcare company based in Sydney (Australia) founded in 2010 by Joachim Fluhrer. It offers personalized cancer testing, monitors treatment effectiveness, and tracks cancer status closely. It operates on a B2C model. Its chief executive, as recorded, is Joachim Fluhrer. Genostics offers products and services including Personalized Cancer Testing and Cancer Treatment Monitoring. Its focus areas include HealthTech, Diagnostics, Oncology Services and Treatment Monitoring.

Company details

Genostics focuses on personalized cancer testing, using advanced technology to monitor treatment effectiveness and track cancer status in real-time. It enables individuals to keep a close eye on their health through innovative diagnostic services. The company emphasizes accurate, timely insights into cancer progression, supporting better health outcomes without specifying locations or clients.

Products & Services of Genostics

Genostics offers a comprehensive portfolio of products and services, including Personalized Cancer Testing and Cancer Treatment Monitoring.

Personalized Cancer Testing
Diagnostic Services

Monitors cancer treatment effectiveness and tracks status for personalized health insights.

Cancer Treatment Monitoring
Health Monitoring Tools

Provides real-time tracking of cancer status to support ongoing medical care.

Apps and channels of Genostics

its YouTube channel Genostics International has 88 subscribers and 16 videos.

Genostics International
YouTube 88 subscribers 16 videos Science & Technology
Open channel

Videos from Genostics

The most watched videos on Genostics's YouTube channel, Genostics International (88 subscribers). Click a video to play it here.

The detection of Circulating Tumour Cells - Dr. Joachim Fluhrer & Prof. Katharina Pachmann
6.5K views
Circulating Tumour Cells (CTCs) - Dr. Joachim Fluhrer and Prof. Katharina Pachmann
3.1K views
The clinical utility of Maintrac CTC testing - Dr. Joachim Fluhrer and Prof. Katharina Pachmann
1K views
The relevance of CTCs (Circulating Tumour Cells) in the bloodstream - Dr. Fluhrer & Prof. Pachmann
1K views

More on Genostics International.

People of Genostics

1 people are tracked at Genostics (1 in leadership).

NameRoleGroup
Joachim Fluhrer
Founder, CEO, Medical DirectorLeadership
Premium access

Complete people profiles for Genostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of Genostics

The website of Genostics (genostics.com.au) receives about 2.5K visits a month.

  • Monthly visits
    2.5K

    ▲ 27.8% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Genostics

Premium access

Complete news archive for Genostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Genostics

Genostics was founded in 2010.

Genostics is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.

Joachim Fluhrer is the CEO of Genostics, as recorded in our data. They have also founded this company.

Genostics focuses on personalized cancer testing, using advanced technology to monitor treatment effectiveness and track cancer status in real-time. It enables individuals to keep a close eye on their health through innovative diagnostic services. The company emphasizes accurate, timely insights into cancer progression, supporting better health outcomes without specifying locations or clients.

Genostics offers Personalized Cancer Testing and Cancer Treatment Monitoring.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available